MedTrace Logo

The Use of Intensive Care in Critically Ill Cancer Haematological Patients: "TRIAL-OH"

NCT01172132 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1011

Last updated 2016-04-18

No results posted yet for this study

Summary

The purpose of this study is to determine:

* Condition of intensive care unit (ICU) admission in patients with haematological malignancies.
* ICU hospital and up to one year mortality.
* Assessment of post ICU burden and health related quality at 90-d and 1 year.

Conditions

Sponsors & Collaborators

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Elie Azoulay, MD, PhD · Saint-Louis Hospital, Paris, France

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-11-30
Primary Completion
2011-05-31
Completion
2011-11-30

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01172132 on ClinicalTrials.gov